Net Cash Provided by (Used in) Financing Activities of TuHURA Biosciences, Inc./NV from 30 Jun 2011 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
TuHURA Biosciences, Inc./NV quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Jun 2011 to 31 Mar 2025.
  • TuHURA Biosciences, Inc./NV Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $547,878, a 112% decline year-over-year.
  • TuHURA Biosciences, Inc./NV annual Net Cash Provided by (Used in) Financing Activities for 2024 was $29,772,693, a 1019% increase from 2023.
  • TuHURA Biosciences, Inc./NV annual Net Cash Provided by (Used in) Financing Activities for 2023 was $2,660,249, a 88% decline from 2022.
  • TuHURA Biosciences, Inc./NV annual Net Cash Provided by (Used in) Financing Activities for 2022 was $21,635,000, a 17% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

TuHURA Biosciences, Inc./NV Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $547,878 -$5,178,581 -112% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q1 2024 $4,630,703 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q3 2023 $2,000,000 -$3,906,000 -205% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2025 Q1
Q3 2022 $1,906,000 -$11,969,000 -86% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2024 Q1
Q3 2021 $13,875,000 -$9,476,000 -41% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2023 Q1
Q3 2020 $23,351,000 +$16,744,000 +253% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q1
Q3 2019 $6,607,000 +$8,696,000 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2021 Q1
Q3 2018 $2,089,000 -$11,032,247 -123% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019 2020 Q1
Q3 2017 $8,943,247 +$8,688,396 +3409% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2019 Q1
Q3 2016 $254,851 -$2,196,693 -90% 01 Jul 2016 30 Sep 2016 10-Q 10 Nov 2016 2017 Q1
Q3 2015 $2,451,544 +$1,923,993 +365% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2017 Q1
Q3 2014 $527,551 01 Jul 2014 30 Sep 2014 10-Q 16 Nov 2015 2016 Q1
Q3 2012 $2,970,000 +$2,970,000 01 Jul 2012 30 Sep 2012 10-Q/A 20 Dec 2012 2013 Q1
Q2 2012 $0 $0 01 Apr 2012 30 Jun 2012 10-K/A 20 Dec 2012 2012 FY
Q3 2011 $0 01 Jul 2011 30 Sep 2011 10-Q/A 20 Dec 2012 2013 Q1
Q2 2011 $0 01 Apr 2011 30 Jun 2011 10-K/A 20 Dec 2012 2012 FY

TuHURA Biosciences, Inc./NV Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $29,772,693 +$27,112,444 +1019% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $2,660,249 -$18,974,751 -88% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $21,635,000 -$4,406,000 -17% 01 Jul 2021 30 Jun 2022 10-K 18 Sep 2023 2023 FY
2021 $26,041,000 +$19,440,000 +295% 01 Jul 2020 30 Jun 2021 10-K 27 Sep 2022 2022 FY
2020 $6,601,000 +$2,526,812 +62% 01 Jul 2019 30 Jun 2020 10-K 28 Sep 2021 2021 FY
2019 $4,074,188 -$5,175,292 -56% 01 Jul 2018 30 Jun 2019 10-K 18 Sep 2020 2020 FY
2018 $9,249,480 +$780,703 +9.2% 01 Jul 2017 30 Jun 2018 10-K 09 Sep 2019 2019 FY
2017 $8,468,777 -$1,096,630 -11% 01 Jul 2016 30 Jun 2017 8-K 03 Jun 2019
2016 $9,565,407 +$8,717,616 +1028% 01 Jul 2015 30 Jun 2016 10-K 13 Sep 2016 2016 FY
2015 $847,791 -$1,632,959 -66% 01 Jul 2014 30 Jun 2015 10-K 13 Sep 2016 2016 FY
2014 $2,480,750 01 Jul 2013 30 Jun 2014 10-K 16 Nov 2015 2015 FY
2012 $7,484 +$7,484 01 Jul 2011 30 Jun 2012 10-K/A 20 Dec 2012 2012 FY
2011 $0 01 Jul 2010 30 Jun 2011 10-K/A 20 Dec 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.